Technology Marathon

As part of both our Automotive Hour and Technology Marathon series, partners Brent Hawkins and Daniel Savrin will discuss how automotive industry participants are navigating standard essential patents (SEPs), including licensing negotiations, contracting, competition considerations, and litigation.

This session looks at the federal–state jurisdiction debate, customer protection and market integrity expectations for sports event contracts, and the practical risks for leagues, media companies, and consumer tech brands that list, distribute, promote, or partner with these platforms.

This program will examine the legal risks surrounding AI and software-facilitated information exchanges, benchmarking, and pricing practices, including where data sharing and algorithmic decision-making may cross antitrust red lines.

This session will explore emerging IP issues and trends unique to the aerospace and defense industry, including challenges surrounding IP ownership, protection, licensing, government rights, and commercialization.

AI is moving from experimentation to a core part of how investment managers operate, invest, report, and manage risk. Please join us as we explore how AI is transforming the investment process, fund operations, disclosure and marketing, and governance frameworks across the investment funds industry.

Join us for a lively discussion on current artificial intelligence issues and legislative developments impacting copyright and right of publicity in the United States, as well as the practical implications of using generative AI in content creation.

Please join us for this discussion on artificial intelligence patent protection and litigation. Topics will include the varieties of AI, determining patentability based on subject matter, novelty, and nonobviousness, inventorship issues, and strategies and tactics for securing favorable outcomes in AI patent disputes.

This session will examine emerging product liability theories involving AI, key defenses and risk mitigation strategies, and how AI is transforming the defense of product liability litigation—from discovery and expert development to trial preparation.

This webinar will discuss the FDA’s policies on the use of artificial intelligence and related technologies for pharmaceutical and medical device development and operations, regulations regarding health-related uses of AI, and other recent developments, including the growth and expansion of FDA’s own use of AI in regulating medical products.

Please join us for a discussion of emerging issues in contracts involving artificial intelligence tools, AI-enabled services, outsourcing arrangements, and other commercial transactions.

This presentation by the data analytics and governance team will examine how long-standing doctrines of attorney-client privilege and attorney work product apply in the context of generative AI (GenAI).

As federal regulation on AI products continues to dominate the dialogue, state attorneys general are increasingly shaping AI governance through investigations, enforcement actions, and consumer protection initiatives. Companies must navigate a rapidly changing patchwork of legal requirements while managing innovation, compliance, and litigation risk.

We will examine the key trends shaping the emerging companies and venture capital deal market in 2026, including developments across venture financings, growth equity, private equity, M&A, and exits. The discussion will address activity across the AI ecosystem, from frontier model companies to the infrastructure, data, tooling, software, enterprise, and other “picks and shovels” businesses supporting AI adoption.

Every year, threat actors targeting companies get more creative. Our team will discuss global trends defining the incident response landscape in 2026 and how to navigate these complex crisis situations.

This webinar will cover recent privacy and data security developments on Capitol Hill and at the US Federal Communications Commission and US Federal Trade Commission.

Remote work introduces additional complexity to evolving cyber risks and presents challenges for businesses across industries. We will discuss these risks and common recommendations for risk reduction.

We will discuss how governments and regulatory agencies are increasingly focusing on a new era of “active” online digital safety and content moderation, including changes in law and regulation that will impact technology industry stakeholders globally.

We will explore the current state of online children’s safety and privacy compliance across overlapping US laws and enforcement and litigation trends.

We will explore the legal, regulatory, and practical dimensions of domain abuse and provide actionable strategies to identify, mitigate, and respond to abuse at its source—helping organizations disrupt cyber threats before they escalate.

This session will cover data privacy, FDA oversight, and HIPAA to unpack where everyday technology interacts with sensitive personal information.